jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Aug. 10, 2006

Dec. 17, 2018

jRCT2080220290

Add-on, open-label, phase III study of CS-866AZ

version:
date:

DAIICHI SANKYO COMPANY, LIMITED

http://www.daiichisankyo.co.jp/contact/index.html

Interventional

Open

3

Patient with essential hypertension not adequately controlled by CS-866 and CS-905 monotherapy, aged 20 years or older

20age old over
No limit

Both

Essential hypertension

investigational material(s)
Generic name etc : CS-866AZ (olmesartan medoxomil / azelnidipine)
INN of investigational material : olmesartan medoxomil/azelnidipine
Therapeutic category code : 214 Antihypertensives
Dosage and Administration for Investigational material : Oral

Efficacy and safety

DAIICHISANKYO Co.,Ltd.

JapicCTI-060295

History of Changes

No Publication date
9 Dec. 17, 2018 (this page) Changes
8 Oct. 18, 2010 Detail Changes
7 Oct. 18, 2010 Detail Changes
6 June. 28, 2010 Detail Changes
5 June. 28, 2010 Detail Changes
4 April. 01, 2007 Detail Changes
3 April. 01, 2007 Detail Changes
2 Aug. 10, 2006 Detail Changes
1 Aug. 10, 2006 Detail